<table id="ID_90D773FF-5C8E-44AD-B843-E10CE16A2407" width="75%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="ID_72167EC8-4DD3-465E-808D-32FC208887AD">Table 3: Incidence of Primary Endpoint Events</caption>
<col align="left" valign="top" width="20%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="10%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="10%"></col>
<thead>
<tr id="ID_7B5022BD-F5A3-4750-9D27-F92E49A019D7">
<td></td>
<td colspan="2">Incidence</td>
<td>Risk Reduction</td>
<td>95% C.I.</td>
<td>p-Value</td>
</tr>
<tr id="ID_41B4B0C8-380A-447A-8328-1E035562889B">
<td></td>
<td>Losartan</td>
<td>Placebo</td>
<td></td>
<td></td>
<td></td>
</tr>
</thead>
<tbody>
<tr id="ID_6FCF05C1-9C7A-404C-BCC8-3CA5B7070380">
<td align="left" colspan="1" rowspan="1">
<br/>Primary Composite Endpoint</td>
<td align="center" colspan="1" rowspan="1">
<br/>43.5%</td>
<td align="center" colspan="1" rowspan="1">
<br/>47.1%</td>
<td align="center" colspan="1" rowspan="1">
<br/>16.1%</td>
<td align="center" colspan="1" rowspan="1">
<br/>2.3% to 27.9%</td>
<td align="center" colspan="1" rowspan="1">
<br/>0.022</td>
</tr>
<tr id="ID_2F409B49-CDCB-470A-8F5D-646880E1B883">
<td align="left" colspan="6" rowspan="1"> <br/> Doubling of Serum Creatinine, ESRD and Death Occurring as a First Event</td>
</tr>
<tr id="ID_4D604AA2-AD22-4D68-9E20-DF525370975D">
<td align="left" colspan="1" rowspan="1">      Doubling of Serum Creatinine</td>
<td align="center" colspan="1" rowspan="1">21.6%</td>
<td align="center" colspan="1" rowspan="1">26.0%</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
</tr>
<tr id="ID_CA96FC7C-3590-4349-B136-984CD6B82424">
<td align="left" colspan="1" rowspan="1">      ESRD</td>
<td align="center" colspan="1" rowspan="1">8.5%</td>
<td align="center" colspan="1" rowspan="1">8.5%</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
</tr>
<tr id="ID_D4D5C0DF-9832-47FB-B05D-A198FE0FB39C">
<td align="left" colspan="1" rowspan="1">      Death</td>
<td align="center" colspan="1" rowspan="1">13.4%</td>
<td align="center" colspan="1" rowspan="1">12.6%</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
<td align="center" colspan="1" rowspan="1">
<br/>
</td>
</tr>
<tr id="ID_C2E0856D-2EC4-4462-BC68-4327C9BA75A0">
<td align="left" colspan="6" rowspan="1">
<br/>Overall Incidence of Doubling of Serum Creatinine, ESRD and Death</td>
</tr>
<tr id="ID_738CB3BD-99D8-49C1-B417-F1B4F9542A83">
<td align="left" colspan="1" rowspan="1">     Doubling of Serum Creatinine</td>
<td align="center" colspan="1" rowspan="1">21.6%</td>
<td align="center" colspan="1" rowspan="1">26.0%</td>
<td align="center" colspan="1" rowspan="1">25.3%</td>
<td align="center" colspan="1" rowspan="1">7.8% to 39.4%</td>
<td align="center" colspan="1" rowspan="1">0.006</td>
</tr>
<tr id="ID_9A5D622E-34FB-432F-88FB-8013F299B457">
<td align="left" colspan="1" rowspan="1">     ESRD</td>
<td align="center" colspan="1" rowspan="1">19.6%</td>
<td align="center" colspan="1" rowspan="1">25.5%</td>
<td align="center" colspan="1" rowspan="1">28.6%</td>
<td align="center" colspan="1" rowspan="1">11.5% to 42.4%</td>
<td align="center" colspan="1" rowspan="1">0.002</td>
</tr>
<tr id="ID_3C18406F-E04E-434F-A101-322AD914CBE0">
<td align="left" colspan="1" rowspan="1">     Death</td>
<td align="center" colspan="1" rowspan="1">21.0%</td>
<td align="center" colspan="1" rowspan="1">20.3%</td>
<td align="center" colspan="1" rowspan="1">-1.7%</td>
<td align="center" colspan="1" rowspan="1">-26.9% to 18.6%</td>
<td align="center" colspan="1" rowspan="1">0.884</td>
</tr>
</tbody>
</table>